Five Transformative HR Trends for 2022
Vanessa Ribreau, our Chief People Officer, shares her thoughts on the changing nature of work and how HR will adapt in the coming year.
Vanessa Ribreau, our Chief People Officer, shares her thoughts on the changing nature of work and how HR will adapt in the coming year.
CEOs must invest heavily to drive meaningful change around DEI. For this to happen, the DEI function should report directly to the CEO, like at BenchSci.
Claudia Hung, Ph.D. and Scientific Support Specialist at BenchSci, gives us insight into her perspective on working to empower other scientists.
Our VP of Engineering, Asaf Inger, has interviewed over 500 job applicants and often sees them struggle with a few key elements, which he discusses here.
Read how the lack of software innovation for preclinical R&D exacerbates pharma’s productivity crisis, and what we can do to address it.
As more scientists now have limited time at the bench, here are some ways to leverage BenchSci at home to prepare for your experiments before you head to the lab.
Investors have mistakenly avoided the preclinical R&D software market. This is the key reason it languishes. And why the opportunity is so untapped.
Bench scientists doing preclinical R&D for diseases like COVID-19 haven’t benefited equally from the productivity software revolution. This must change.
An infographic explaining why designing and developing bioinformatic tools can be challenging for scientists and the resulting frustrating user experience.